Table 5.
Findings from clinical studies on combined effects of resveratrol and exercise training in humans, comparing exercise training alone (ET) to exercise training combined with resveratrol supplementation (REX).
| Study | Species | Age | Training | Resveratrol dosage | Response to ET vs. sedentary | Response to REX |
|---|---|---|---|---|---|---|
| Olesen et al. (44) | Men | 65±1 years | 8-week endurance | 250 mg | Increased PGC-1a mRNA; increased exercise performance; reduced TNFa mRNA | PGC-1a: no extra effect; performance (one-legged knee-extensor): no additional effect of resveratrol; no effect of resveratrol on adenosine monophosphate (AMP)-activated protein kinase (AMPK) and sirtuin 1 (SIRT1); resveratrol impaired training-induced reduction of TNFa mRNA |
| Gliemann et al. (15) | Men | 65±1 years | 8 weeks of high-intensity training | 250 mg | Greater increase in VO2max; reduced mean arterial pressure; reduced low-density lipoprotein (LDL), total cholesterol/high-density lipoprotein (TC/HDL) ratio, and triglyceride concentrations (TGs) in blood | 45% lower VO2max than in REX; no additional reduction in mean arterial pressure, only in placebo; REX abolished the training effect on LDL, TC/HDL, and TGs; no effect of REX on SIRT1 |
| Gliemann et al. (14) | Men | 65±1 years | 8 weeks of high-intensity training | 250 mg | ~20% increase in capillary to fiber ratio (C:F), an increase in the muscle protein expression of vascular endothelial growth factor (VEGF). | No increase in C:F ratio and VEGF protein expression. |